{"filename": "Profounda Inc._1838.html", "defect": "Lack of identity testing for diethylene glycol (DEG) in glycerin", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Your firm failed to withhold each lot of components, drug product containers, and closures until tested and released, and lacked a specific identity test to detect diethylene glycol (DEG) in glycerin shipments."}
{"filename": "Tianjin Bolang Science-Technology Development Co. Ltd._2886.html", "defect": "Lack of design control procedures and activities for the device.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Medical devices", "fda_critique": "The firm\u2019s response is not adequate because it failed to provide details on processes, work operations, quality records, and other quality data necessary for a retrospective review and did not ensure the availability of complaint procedure and records for review."}
{"filename": "Zyno Medical LLC_2193.html", "defect": "Leaking administration sets with compromised filter integrity.", "claimed_cause": "Device not returned; no cause established.", "product_type": "Medical devices", "fda_critique": "The investigation lacked a thorough evaluation of complaints due to failure to return devices for testing and insufficient documentation of any additional investigative efforts."}
{"filename": "Landy International_1068.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a comprehensive assessment of omissions, alterations, deletions, record destruction, and other deficiencies within the facility\u2019s operations regarding data integrity."}
{"filename": "Zydus Lifesciences Limited_928.html", "defect": "Cross-contamination from inadequate cleaning of drug products.", "claimed_cause": "Inadequate cleaning, shared equipment, and testing alone caused contamination.", "product_type": "Drugs", "fda_critique": "Your investigation failed to adequately consider all impacted batches, manufacturing equipment, and testing methods used to release contaminated drug products."}
{"filename": "Becton Dickinson and CompanyCareFusion 303 Inc._785.html", "defect": "Delay in dispensing medications due to freezing, shutdown, or malfunction.", "claimed_cause": "Complaint investigations were not comprehensive, lacking detailed investigation and root cause analysis.", "product_type": "Other", "fda_critique": "Failed to adequately investigate and address a significant number of complaints regarding medication dispensing delays, malfunctions, and potential patient safety issues, including those leading to life-threatening situations."}
{"filename": "Zhejiang Tianyu Pharmaceutical Co. Ltd._2092.html", "defect": "High impurity concentration in API batches.", "claimed_cause": "Operator error during batch preparation, equipment malfunction, raw material contamination.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation failed to extend its scope to all lots manufactured prior to August 2018, including those using the non-optimized manufacturing process."}
{"filename": "Accra-Pac Inc. dba Voyant Beauty_1783.html", "defect": "Benzene contamination in drug products at unacceptable levels.", "claimed_cause": "Operator error during propellant blending, inadequate testing, and flawed investigation scope.", "product_type": "Topical products", "fda_critique": "Failed to thoroughly investigate any unexplained discrepancy or failure of a batch or its components to meet specifications, and did not expand its investigation to other propellants when information indicated benzene contamination in cosmetic products using a different propellant."}
{"filename": "Argon Medical Productions  Vertrieb Gesellschaft MBH  CO_852.html", "defect": "Failure of dental implants to osseointegrate", "claimed_cause": "Complaints due to patient-specific factors are not investigated.", "product_type": "Medical devices", "fda_critique": "Your firm failed to adequately investigate complaints involving device failures, such as osseointegration, and did not provide documentation or evidence of proposed corrective actions."}
{"filename": "Chemspec Chemicals Private Limited_20.html", "defect": "Batch manufacturing records lacking complete information and data.", "claimed_cause": "Operator error and deficient data integrity practices.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your quality unit failed to investigate and correct deficiencies in batch manufacturing record issuance and data integrity practices."}
{"filename": "MD Pharmaceutical Supply LLC_1948.html", "defect": "Disparate API expiration dates for the same lot.", "claimed_cause": "Failure to investigate supplier complaints and assess API quality.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to initiate an investigation to assess whether the change in expiration date for aminocaproic acid API was accurate and appropriate."}
{"filename": "Jamol Laboratories Inc._1624.html", "defect": "Failed identification test - lacking infrared spectroscopy for Eucalyptus Oil", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "The investigation lacked scientifically sound and appropriate specifications, standards, sampling plans, and test procedures designed to assure that components conform to appropriate standards of identity, strength, quality, and purity, and failed to include an identification test with adequate specificity for incoming Eucalyptus Oil."}
{"filename": "ABR Laboratory LLC_707.html", "defect": "Out-of-range temperature in 2-8\u00b0C refrigerator compromising microorganisms.", "claimed_cause": "Failure to investigate temperature deviations, no root cause identified.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to thoroughly investigate unexplained deviations in laboratory equipment, including temperature and humidity readings, and determine their potential impact on test results."}
{"filename": "Yiling Pharmaceutical Ltd._492.html", "defect": "Cross-contamination hazards from inadequate cleaning procedures.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Other", "fda_critique": "The investigation lacked a comprehensive assessment of your cleaning effectiveness to evaluate the scope of cross-contamination hazards."}
{"filename": "Aurobindo Pharmaceutical Limited_2582.html", "defect": "Observed peak splitting during GC-MS method transfer.", "claimed_cause": "Dirty/deteriorated column was attributed as the root cause.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation failed to consider all potential equipment sources contributing to the observed peak splitting during the method transfer."}
{"filename": "NDAL Mfg Inc._2458.html", "defect": "Microbial contamination in ManukaGuard Allercleanse nasal spray.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to extend the investigation to other batches and drug products associated with the microbial contamination."}
{"filename": "Visgeneer Inc_379.html", "defect": "Lack of documented customer complaints for blood glucose monitoring systems", "claimed_cause": "Personnel unaware of complaint requirements, inadequate procedure.", "product_type": "Medical devices", "fda_critique": "Your firm did not adequately review communications, including those previously categorized as \u201cinquires,\u201d to determine if they should be retrospectively handled as complaints."}
{"filename": "Dental Technologies Inc._2658.html", "defect": "Excessive aerobic plate counts and Burkholderia cepacia complex contamination.", "claimed_cause": "Lack of data; API supplier contamination of chlorhexidine gluconate.", "product_type": "Oral solid dosage", "fda_critique": "Your investigation failed to adequately address multiple potential root causes of the contamination, including deficiencies in your cleaning program and lacked justification for attributing the contamination solely to the API supplier\u2019s issues."}
{"filename": "Centaur Pharmaceuticals Private Ltd._1631.html", "defect": "Inconsistent peak response in long-term dissolution samples.", "claimed_cause": "Interference from excipients and insufficient filter saturation.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "You failed to provide scientific justification for concluding that extraneous peaks in stability samples were due to insufficient filter saturation, lacking an appropriate assessment of your procedures for investigating discrepancies."}
{"filename": "GFA Production Xiamen Co. Ltd._1070.html", "defect": "Objectionable microbial contamination", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked sufficient detail regarding the root causes of contamination and the identification of inadequacies of cleaning procedures."}
{"filename": "Omega Packaging Corp_1803.html", "defect": "Data integrity lapses in records and reporting.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "The company\u2019s investigation failed to ensure adequate oversight and address critical deficiencies in its quality systems, including cleaning validation, stability programs, data integrity controls, and batch records."}
{"filename": "Daewoo Pharmaceutical Co. Ltd._414.html", "defect": "Raw material contamination with high-risk components.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a meaningful investigation into the trend of multiple mold recoveries, including a significant recovery of *Cladosporium*, and failed to open an investigation to examine other potentially adverse trends."}
{"filename": "P.T. Sankei Medical Industries_1161.html", "defect": "Missing Quality Assurance and Reference Documentation in DMRs", "claimed_cause": "NOT STATED", "product_type": "Medical devices", "fda_critique": "The firm\u2019s investigation lacked documented evidence of conducting quality audits to assure compliance with quality system requirements and determine system effectiveness."}
{"filename": "Vi-Jon LLC_2414.html", "defect": "Water leaks from the purification system and valve leaks.", "claimed_cause": "Operator error due to lack of documented leak checks.", "product_type": "Oral solid dosage", "fda_critique": "Your investigation failed to adequately document and address water leaks within the purification system, presenting a potential entry point for microbial contamination."}
{"filename": "DeVere Manufacturing Inc._73.html", "defect": "Unsuitable component water used in hand sanitizer formulation.", "claimed_cause": "Inadequate quality systems, failing to investigate test results.", "product_type": "Other", "fda_critique": "The firm\u2019s quality control unit failed to adequately investigate out-of-specification test results, reprocessing, and errant label reconciliation, and failed to establish and follow written procedures."}
{"filename": "EpiCare Acquisitions LLC_615.html", "defect": "Failure to investigate and report complaints related to laser device issues.", "claimed_cause": "Failure to investigate complaints; no root cause identified.", "product_type": "Medical devices", "fda_critique": "Your firm failed to maintain a record that includes the reason no investigation was made and the name of the individual responsible for the decision not to investigate."}
{"filename": "Nortec Quimica SA_1954.html", "defect": "Data integrity lapses in records and reporting.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The company\u2019s investigation failed to adequately ensure the accuracy and integrity of data to support the safety, effectiveness, and quality of the drugs it manufactures."}
{"filename": "Unimicro Medical Systems-Shenzhen Co. Ltd._2480.html", "defect": "Not specified", "claimed_cause": "NONE IDENTIFIED", "product_type": "Medical devices", "fda_critique": "Your firm did not adequately establish and maintain procedures to ensure equipment is routinely calibrated, inspected, checked, and maintained, and failed to provide calibration documentation and data for key instruments."}
{"filename": "Tower Laboratories Ltd._23.html", "defect": "Out-of-specification assay testing failure at stability timepoint", "claimed_cause": "Microscopic packaging defects led to failure, no root cause.", "product_type": "Oral solid dosage", "fda_critique": "Your investigation lacked sufficient rigor to show how your \u201cpackaging defects\u201d led to a failure in product quality and failed to initiate a CAPA."}
{"filename": "Professional Compounding Centers of America dba PCCA_3255.html", "defect": "Failure to ensure cleaning practices prevented contamination.", "claimed_cause": "Failure to ensure cleaning practices were adequate to prevent contamination", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a sufficient evaluation of the recurring CGMP deficiencies and failure to maintain complete data for API tested and distributed to the United States."}
{"filename": "Yusef Manufacturing Laboratories LLC_2424.html", "defect": "Failing assay result for meradimate API and octisalate API.", "claimed_cause": "Heated filling nozzles at the start of production.", "product_type": "Topical products", "fda_critique": "Failed to conduct a full-scale investigation, including evaluating the manufacturing process, to determine the root cause of the failing assay results and prevent recurrence."}
{"filename": "K.C. Pharmaceuticals Inc._1549.html", "defect": "Multiple media fill failures - contaminated units", "claimed_cause": "Investigations had not been closed; failures were not addressed.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The company\u2019s investigation lacked adequate scientific justification for invalidating media fill failures and failing to address the root cause of contamination events."}
{"filename": "Janssen Vaccines Corp. A Johnson  Johnson Company_228.html", "defect": "Cracked vial stoppers associated with human use factors.", "claimed_cause": "Human use factors, including container closure system assembly.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your firm did not adequately investigate other human use factors, such as the effect of container closure systems, and lacked investigation of the potential effects of manufacturing factors."}
{"filename": "Sovereign Pharmaceuticals LLC_2040.html", "defect": "Insufficiently shallow sampling thief insertion causing extra force.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Your firm failed to extend its investigation to all similarly impacted drug products and adequately assess other sources of variability."}
{"filename": "Excelvision Fareva_560.html", "defect": "Mold, black specks, and discoloration on drug products", "claimed_cause": "Inadequate investigations attributed mold to customer handling/water leaks.", "product_type": "Oral solid dosage", "fda_critique": "Your investigation lacked a scientifically supported determination of root cause(s) and failed to include an evaluation of customer complaint samples."}
{"filename": "NeilMed Pharmaceuticals Inc._1668.html", "defect": "Unidentified visible residues on direct product contact surfaces.", "claimed_cause": "Inadequate cleaning, lack of QA oversight, and operational management failures.", "product_type": "Oral solid dosage", "fda_critique": "Failed to provide a comprehensive, independent retrospective assessment of cleaning effectiveness to evaluate the scope of cross-contamination hazards and identify inadequacies of cleaning procedures and practices."}
{"filename": "Spartan Chemical Company Inc._2627.html", "defect": "Recurring failing microbial enumeration results exceeding limits.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigations into failing results did not identify the root cause of the failures, lacked an evaluation of the impact on distributed batches, and did not include appropriate CAPA."}
{"filename": "Prime Lab LLC_1315.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Other", "fda_critique": "Your firm\u2019s investigation lacked a comprehensive assessment and remediation plan to ensure adequate investigation competencies, scope determination, root cause evaluation, and CAPA effectiveness."}
{"filename": "Onkos Surgical Inc._396.html", "defect": "Taper post misalignment, mislabeled stems, and incorrect stem sizes", "claimed_cause": "Firm\u2019s SOP is ambiguous and subjective.", "product_type": "Medical devices", "fda_critique": "The firm\u2019s investigation lacked assurance that it will make appropriate decisions following 21 CFR 806 in the future, based on a root cause stating that the firm\u2019s SOP is ambiguous and subjective."}
{"filename": "NWL Netherlands Services B.V._533.html", "defect": "Out-of-limit (OOL) results for microbial content", "claimed_cause": "NONE IDENTIFIED", "product_type": "Drugs", "fda_critique": "Failed to provide a comprehensive, independent assessment of the overall system for investigating deviations and out-of-specification results, including a detailed action plan."}
{"filename": "Bell International Laboratories Inc._1231.html", "defect": "Missing testing records and out-of-specification (OOS) investigations", "claimed_cause": "Inadequate investigations, missing records, no root cause identified.", "product_type": "Other", "fda_critique": "Your investigations lacked adequate root cause determinations, corrective action and preventive action (CAPA), and effectiveness checks."}
{"filename": "Glenmark Pharmaceuticals Limited_403.html", "defect": "Dissolution failures for potassium chloride ER capsules", "claimed_cause": "Raw material contamination from API", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation did not adequately determine root cause(s) of your repeated dissolution failures during long-term stability testing, failing to consider all potassium chloride ER capsule process changes that may have impacted the dissolution results."}
{"filename": "Denison Pharmaceuticals LLC_1596.html", "defect": "Lubricant contamination with a non-food grade lubricant.", "claimed_cause": "Your firm concluded only Lot (b)(4) was impacted, no CAPA required.", "product_type": "Other", "fda_critique": "Failed to perform adequate investigations and expand investigations to all batches and drug products that may have been impacted from contamination by machinery lubricant."}
{"filename": "Legacy Pharmaceutical Packaging LLC_2072.html", "defect": "Foreign tablets detected in repackaged drug products.", "claimed_cause": "Operator error during batch preparation, equipment design flaws.", "product_type": "Oral solid dosage", "fda_critique": "Failed to extend the investigation to determine whether other batches may also have been impacted."}
{"filename": "I.T.S. GmbH_1763.html", "defect": "Dimensional deviation of the product components", "claimed_cause": "Events caused by employees, equipment, document failure, or other causes.", "product_type": "Medical devices", "fda_critique": "Your firm\u2019s investigation lacked adequate documentation of investigation, implementation of corrective actions, and distribution of quality issues to relevant personnel."}
{"filename": "Envoy Medical Inc._76.html", "defect": "Delayed complaint investigations leading to device failures.", "claimed_cause": "Calibration drift in analytical equipment.", "product_type": "Medical devices", "fda_critique": "The investigation lacked timely and thorough investigation of complaints, failing to follow established protocols and assign responsibility for engineering reviews within required timeframes."}
{"filename": "Eugia Pharma Specialities Limited_964.html", "defect": "Vial breakage leading to media spill and contamination.", "claimed_cause": "Vial breakage led to media spill contamination, operators unconsidered.", "product_type": "Sterile products", "fda_critique": "Failed to adequately consider operators as the likely source of contamination and did not investigate potential design flaws contributing to the contamination."}
{"filename": "Integra LifeSciences Corporation_1598.html", "defect": "Bacterial endotoxin (BET) result exceeding specification limits", "claimed_cause": "Transcription error due to a different lot\u2019s result.", "product_type": "Medical devices", "fda_critique": "Your investigation lacked sufficient analysis of the transcription error and failure to identify all potential causes of nonconforming product."}
{"filename": "Pers\u014dn  Covey Inc._211.html", "defect": "Out-of-specification active ingredient content test results.", "claimed_cause": "There was never a formal procedure for Data Integrity.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your quality system did not adequately ensure the accuracy and integrity of data to support the safety, effectiveness, and quality of the drugs you manufacture."}
{"filename": "Accupack Midwest Inc._896.html", "defect": "Inadequate specifications and testing for component water.", "claimed_cause": "Lack of adequate water specifications and monitoring.", "product_type": "Oral solid dosage", "fda_critique": "The investigation lacked adequate specifications, standards, and testing for the water system, including limits and testing for objectionable microorganisms and conductivity, leading to failures in monitoring and ensuring water met Purified Water USP specifications."}
{"filename": "RoyalVibe Health Ltd._1946.html", "defect": "Bioresonance Focused Ultrasound Generator claims of healing conditions.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Medical devices", "fda_critique": "The investigation lacked scientific justification for claims regarding the effectiveness of the devices in treating diseases like cancer and Alzheimer\u2019s."}
{"filename": "Eco Lips Inc._1795.html", "defect": "Out-of-specification assay results for OTC drug batches.", "claimed_cause": "Operator error (allowing average results) and failure to investigate.", "product_type": "Oral solid dosage", "fda_critique": "The firm failed to initiate timely investigations to determine root causes and assess the impact of out-of-specification (OOS) assay results, and did not implement appropriate corrective actions to mitigate recurrence."}
{"filename": "Catalent Indiana LLC_72.html", "defect": "Extrinsic mammalian hair contamination in vials and stoppers", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Your investigations frequently lacked data supporting the assigned root cause(s), were not adequately expanded to include all potentially affected drug products."}
{"filename": "Edge Biologicals Inc._1652.html", "defect": "Sterility failures of Mueller Hinton Agar lots", "claimed_cause": "Failure to validate processes, analyze data, and implement procedures.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The company\u2019s investigation lacked adequate analysis of quality data and failure to investigate and identify actions needed to correct and prevent the recurrence of product sterility failures."}
{"filename": "Intas Pharmaceuticals Limited_1623.html", "defect": "Invalidated OOS (in-process and release/stability testing) results", "claimed_cause": "NONE IDENTIFIED", "product_type": "Other", "fda_critique": "Failed to adequately address how you will implement systems to identify and address adverse laboratory incident trends and provide an overall management strategy for improving all phases of your laboratory investigations."}
{"filename": "Miami University Department of Chemistry and Biochemistry_2376.html", "defect": "Lack of conclusive, quantitative data for heparin elements.", "claimed_cause": "Data manipulation motivated by avoiding reanalysis was the root cause.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked conclusive, quantitative data for any of the elements reported, indicating the product had not been adequately analyzed for pharmaceutical quality."}
{"filename": "Medline Industries LP_1215.html", "defect": "Cracked, broken, or leaking syringes during use.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Medical devices", "fda_critique": "Failed to properly investigate customer complaints regarding quality issues and cracks/breakage in syringes from Jiangsu Shenli."}
{"filename": "LEVO AG_171.html", "defect": "Missing documentation for key quality system requirements", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The company\u2019s investigation lacked documentation to establish requirements across key areas of its Quality System, as mandated by 21 CFR 820."}
{"filename": "Invacare Corporation_2688.html", "defect": "Possible failure of a device to meet specifications", "claimed_cause": "\u201cRoot cause: lack of complaint investigation procedures\u201d", "product_type": "Medical devices", "fda_critique": "Your investigation lacked the requirement to investigate complaints involving device failures, labeling, or packaging issues, regardless of whether they caused injury, illness, or death."}
{"filename": "Columbia Cosmetics Manufacturing Inc._266.html", "defect": "Subpotent API concentration in bulk drug product.", "claimed_cause": "API \u201cevaporation\u201d was not scientifically supported.", "product_type": "Topical products", "fda_critique": "Your investigation failed to thoroughly investigate unexplained discrepancies and failures in drug products, including the subpotent API batch, and did not identify a scientifically supported root cause or implement appropriate corrective actions."}
{"filename": "Wissner-Bosserhoff GmbH_942.html", "defect": "Electrical nonfunctional motor failures in the motor article.", "claimed_cause": "Lack of knowledge and training regarding CAPA requirements.", "product_type": "Medical devices", "fda_critique": "The investigation lacked a comprehensive review of all test equipment to ensure suitability and validity of results."}
{"filename": "Virgin Scent Inc. dba Artnaturals_2125.html", "defect": "Failing to examine incoming components & release testing.", "claimed_cause": "Inadequate QU oversight, failing to examine components, release testing.", "product_type": "Oral solid dosage", "fda_critique": "Your firm\u2019s investigations lacked adequate procedures and a thorough evaluation of potential causes, particularly regarding the failure to examine incoming components and perform release testing prior to product release."}
{"filename": "Taizhou Kangping Medical Science and Technology Co. Ltd._132.html", "defect": "Exceeding allowable concentration of active ingredient in product.", "claimed_cause": "Lack of validated controls, shared access, and unretained spreadsheets.", "product_type": "Oral solid dosage", "fda_critique": "The firm\u2019s investigation lacked sufficient controls over data acquisition systems and failed to ensure the accuracy and integrity of data to support product safety, effectiveness, and quality."}
{"filename": "Dunagin Pharmaceuticals Inc. dba Massco Dental_1819.html", "defect": "Out-of-specification (OOS) finished drug product assay results", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Your investigation did not include sufficient detail as to the possible scope and probable root cause for the OOS results observed during the inspection."}
{"filename": "Sterling Pharmaceutical Services LLC_2082.html", "defect": "Sterility failure \u2013 contaminated with Herbaspirillum aquaticum bacterium.", "claimed_cause": "Poor aseptic behavior by personnel, very low risk.", "product_type": "Sterile products", "fda_critique": "Your investigation failed to thoroughly address the persistent adverse trend of microorganisms recovered from ISO 5 areas, including spore-forming bacteria and fungi, and did not consider that this sterility failure may be indicative of contamination risks from the basic design of your processing lines."}
{"filename": "Akron Formulations India Private Limited_763.html", "defect": "BCC organisms detected in docusate sodium drug products", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigations lacked sufficient detail regarding the root causes of contamination and failed to adequately study the ability of your system to inhibit objectionable organisms."}
{"filename": "Episciences Inc._2158.html", "defect": "Out-of-specification assay results for zinc oxide in sunscreen.", "claimed_cause": "Sampling error and non-homogenous blending sample caused the failures.", "product_type": "Oral solid dosage", "fda_critique": "Your investigations into OOS laboratory results lacked scientifically supported conclusions, corrective actions, and preventive actions, and failed to adequately identify the root cause and assess whether other batches were affected."}
{"filename": "DSAART LLC. dba Alpha Aesthetics_2625.html", "defect": "Failed gluteal implant implantation, removal due to inflammation, and device breakage.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Sterile products", "fda_critique": "Your firm did not adequately investigate complaints, failing to document the nature of investigations, results, and justifications for not investigating, as demonstrated by missing or incomplete documentation of key complaints."}
{"filename": "Aizu Olympus Co. Ltd._1930.html", "defect": "Inadequate curing of the adhesive bonding/gluing process.", "claimed_cause": "No requirement to record curing time/cleaning parameters.", "product_type": "Medical devices", "fda_critique": "Failed to adequately document and address critical process parameters like curing time and ultrasonic cleaning parameters within Design History Records."}
{"filename": "Microspecialties LLC_546.html", "defect": "Released sterile products to inventory without sterilization COPs.", "claimed_cause": "Limited resources, training, storage, and sterilization label deficiencies.", "product_type": "Medical devices", "fda_critique": "The investigation lacked a thorough validation of the sterilization process due to the failure to fully verify results and implement established procedures."}
{"filename": "Sombra Cosmetics Inc._765.html", "defect": "Microbial growth (yeast and mold) detected in drug products.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Failed to establish an adequate quality control unit with the responsibility and authority to oversee manufacturing and ensure product quality."}
{"filename": "Greco Gas Inc._905.html", "defect": "Container-closure defects (neck leaks and valves) in medical gases.", "claimed_cause": "Operator error, documentation discrepancies, and failure to investigate issues.", "product_type": "Medical devices", "fda_critique": "Your firm failed to thoroughly investigate manufacturing and testing discrepancies, including recurrent container-closure defects and instances of missing or inaccurate documentation, demonstrating a lack of adequate investigation into critical quality issues."}
{"filename": "Abraxis Bioscience LLC_2027.html", "defect": "Contaminated media fill units with multiple microbial growth detected", "claimed_cause": "Damaged filling manifold valve contaminated during cleaning.", "product_type": "Sterile products", "fda_critique": "Your investigations into the media fill failures lacked sufficient rigor in determining root causes and scope of impact, failing to adequately address potential issues with sterilization cycle design and equipment contamination."}
{"filename": "Iso-Tex Diagnostics Inc._1628.html", "defect": "Exposed facial skin and hair entering ISO 5 area.", "claimed_cause": "Operator error, inadequate procedures, and failure to follow aseptic practices.", "product_type": "Injectable drugs", "fda_critique": "Your investigation failed to adequately address the contamination hazards stemming from personnel behavior within the ISO 5 area, specifically regarding gowning and glove usage."}
{"filename": "Naturich Cosmetique Labs_190.html", "defect": "Microbiological out-of-limit results from the water system.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Topical products", "fda_critique": "The investigation lacked a comprehensive review for potentially affected products, a root cause determination, and supporting documentation to identify the fundamental flaws in the water system\u2019s design, control, and maintenance contributing to the OOL results."}
{"filename": "Unipack LLC_26.html", "defect": "Out-of-specification assay results for suppository batches.", "claimed_cause": "Improper processing of injection, HPLC inhibition, no root cause.", "product_type": "Oral solid dosage", "fda_critique": "Your investigation failed to provide scientific justification to invalidate OOS results and release batches, lacking root cause identification and appropriate corrective action."}
{"filename": "Baxter Healthcare Corporation_1629.html", "defect": "Particulate matter in endotoxin testing wells", "claimed_cause": "Environmental and laboratory conditions, particulate matter source undefined.", "product_type": "Oral solid dosage", "fda_critique": "Your firm failed to thoroughly investigate unexplained OOS endotoxin testing results, including multiple invalidated tests, without definitively identifying the source of particulate matter and implementing scientifically justified corrective actions."}
{"filename": "Dexcom Inc._632.html", "defect": "Dissolved oxygen content outside specification in G6 sensors.", "claimed_cause": "Inconsistent monitoring, notification, and scrapping of affected sensors.", "product_type": "Medical devices", "fda_critique": "Your investigation lacked adequate evaluation of the potential for compression artifacts to cause delayed or missed low glucose alarms, particularly given the cited literature's findings."}
{"filename": "Professional Disposables International Inc._2599.html", "defect": "Out-of-specification CHG assay results in Prevantics Swabstick and Swab batches.", "claimed_cause": "Pipetting error or incorrect dilution without evidence.", "product_type": "Medical devices", "fda_critique": "Your investigations into OOS test results were inadequate because you failed to thoroughly investigate root causes, expand investigations to affected batches, implement CAPA, and evaluate its effectiveness."}
{"filename": "Fuller Industries Inc._1653.html", "defect": "Not specified", "claimed_cause": "NONE IDENTIFIED", "product_type": "Other", "fda_critique": "The company failed to adequately test samples of each component, including propylene glycol, for identity and conformity with specifications, specifically lacking a USP limit test for diethylene glycol or ethylene glycol."}
{"filename": "Cosmobeauti Laboratories  Manufacturing Inc._1555.html", "defect": "Inaccuracies in data records and reporting", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation lacked a comprehensive evaluation of the extent of inaccuracies in data records and reporting, including a detailed description of root causes."}
{"filename": "Jost Chemical Co._2225.html", "defect": "Gross mold contamination in Potassium Sulfate, USP lot 36830004", "claimed_cause": "Inadequate investigation, failure to expand scope, root cause not stated.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation was inadequate because it did not extend to other potentially affected batches and failed to fully address the scope of the mold contamination problem."}
{"filename": "Lupin Limited_2048.html", "defect": "Quantifiable levels of genotoxic impurities in API batches.", "claimed_cause": "\u201cYour investigation determined impurities were purged effectively, no further monitoring needed.\u201d", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to investigate all critical deviations, including limit excursions."}
{"filename": "Sanofi_738.html", "defect": "Presence of particles in vials leading to OOS results.", "claimed_cause": "Operator error during batch preparation, investigations failed to identify causes.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigations failed to identify all potential contributing causes, consider the conclusions of an engineering study, and adequately document investigational activities."}
{"filename": "The W.S. Badger Company Inc._2383.html", "defect": "High water activity exceeding specifications, combined with microbial growth.", "claimed_cause": "Operator error/moisture in the formulation was the root cause.", "product_type": "Topical products", "fda_critique": "Your investigation did not determine the root cause of the microbial failure or extend the investigation to determine if any additional lots may have been affected."}
{"filename": "Yangzhou Sion Commodity Co. Ltd._630.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a comprehensive assessment of DI deficiencies, including omissions, alterations, and deletions in data records and reporting."}
{"filename": "Noah Medical Corporation_600.html", "defect": "Scope pouches leaking during aging studies.", "claimed_cause": "Failure to identify root causes in CAPA investigations.", "product_type": "Medical devices", "fda_critique": "Your firm failed to adequately conduct and document CAPA investigations, including failing to determine the root cause of identified issues like \u201cbiopsy tools couldn\u2019t pass through bronchoscope\u2019s working channels\u201d and failing to evaluate the extent of pouch leaks."}
{"filename": "Lex Inc._1540.html", "defect": "Incomplete process validation studies and inadequate PPQ results.", "claimed_cause": "Lack of a validation plan is the root cause.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your firm lacked an adequate process validation program and sufficient validation studies for your drug product manufacturing processes, failing to ensure reproducible products that meet specifications."}
{"filename": "Adept Medical Ltd._804.html", "defect": "NeoZoline Ventilation Tubes: Nonconforming tubes not inspected upon arrival.", "claimed_cause": "No risk to end users, postmarket surveillance data.", "product_type": "Medical devices", "fda_critique": "The investigation lacked adequate evaluation of nonconformities and failed to justify the rationale for not conducting related investigations."}
{"filename": "Somerset Therapeutics Private Limited_316.html", "defect": "Visible contamination in media fill failure on filling line", "claimed_cause": "Operator activities related to a breach in tubing.", "product_type": "Oral solid dosage", "fda_critique": "Your investigations lacked data supporting the assigned root cause(s), were not adequately expanded to include all potentially affected drug products, or were not formally documented in your deviation system."}
{"filename": "Strukmyer LLC dba Strukmyer Medical_716.html", "defect": "Microbiological contamination of purified water system.", "claimed_cause": "No product impact because subsequent water samples were within limits.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation did not adequately identify the root cause of the contamination of your water system with objectionable microorganisms and failed to consider the impact to your distributed drug products that were manufactured with contaminated water."}
{"filename": "Ultra Seal Corporation_2436.html", "defect": "Cross-contamination of Pain Aid Extra Strength tablets with guaifenesin \n\nCross-contamination of 3-Component Cold Tabs tablets with caffeine", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Your investigation failed to scientifically identify the root cause of the contamination in multiple instances, relying instead on resampling and retesting with unvalidated methods until passing results were obtained."}
{"filename": "Indoco Remedies Limited_753.html", "defect": "Rough metal surfaces and incomplete barriers in RABS systems.", "claimed_cause": "Improper verification of conduit, improper inspection procedures.", "product_type": "Oral solid dosage", "fda_critique": "Your remediation activities failed to holistically address the conditions of the RABS, and your response did not evaluate the training of personnel responsible for inspection activities."}
{"filename": "LCC Ltd._798.html", "defect": "Inaccuracies in data records and reporting.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a comprehensive assessment of omissions, alterations, deletions, record destruction, and other deficiencies in the facility\u2019s operations regarding data integrity."}
{"filename": "Fresenius Kabi AG_1232.html", "defect": "Inadequate health risk assessments and root cause analyses investigations.", "claimed_cause": "Root cause was identified as inadequate CAPA procedures and investigations.", "product_type": "Medical devices", "fda_critique": "Your investigation lacked adequate root cause analyses and verification of effectiveness for critical CAPAs, including those resulting in Class I recalls."}
{"filename": "Wisconsin Pharmacal Company LLC_331.html", "defect": "Failed assay test release specification for drug product units.", "claimed_cause": "Insufficient batch oversight due to scanning procedure.", "product_type": "Oral solid dosage", "fda_critique": "Your firm did not provide a comprehensive corrective action and preventive action (CAPA) plan with a systematic approach to correct oversight deficiencies."}
{"filename": "DuPont Nutrition USA Inc._1956.html", "defect": "Encrusted conductivity probe causing inaccurate conductivity results.", "claimed_cause": "Elevated ammonium chloride levels in Avicel were the root cause.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation failed to thoroughly investigate OOS results, expand to all potentially affected lots, and implement adequate corrective and preventive actions."}
{"filename": "Phillips Precision Inc._748.html", "defect": "Residue, metal debris, and contamination on devices", "claimed_cause": "Your firm attributed the failure to inadequate verification/validation of corrective actions.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation lacked a thorough verification or validation of corrective actions prior to implementation to ensure their effectiveness."}
{"filename": "Central Admixture Pharmacy Services Inc._970.html", "defect": "100% visual inspection directed in the procedure failed to investigate root causes.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Sterile products", "fda_critique": "Your investigation lacked a thorough evaluation of the root causes and did not ensure corrective actions aligned with SOP-CAPS-4000317."}
{"filename": "Vitae Enim Vitae Scientific Inc._2398.html", "defect": "Ink leaching into drug product solution", "claimed_cause": "Operator error/process failure during transfer tubing investigation.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "You failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications, including a review of other batches of drug products manufactured using the same tubing that may have been adversely affected."}
{"filename": "Sure-Biochem Laboratories LLC_1759.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your firm failed to conduct a retrospective review to ensure materials used for drug product testing were suitable for their intended use."}
{"filename": "ReNovo Inc. DBA Provision Device Reprocessing Solutions_1203.html", "defect": "Above-limit air particulate levels in medical devices.", "claimed_cause": "Air particulate levels above limits, no identified root cause.", "product_type": "Medical devices", "fda_critique": "Your firm did not assess if product may have been impacted by the air compressor failure or set acceptable levels for air particulate measurements."}
{"filename": "Antaria Pty. Ltd._1181.html", "defect": "Out-of-specification assay and loss on ignition (LOI) test results.", "claimed_cause": "Staff turnover and insufficient training, lack of root cause definition.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to describe a holistic review of all investigations\u2019 root cause analyses and corrective actions for adequacy."}
{"filename": "Missouri Analytical Laboratories Inc_2772.html", "defect": "Out-of-specification assay testing results for a batch.", "claimed_cause": "Your firm attributed the failure to laboratory errors.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a comprehensive assessment into the extent of the falsification of autoclave records and other breaches of data integrity occurring in the laboratory."}
{"filename": "Mentha  Allied Products Private Ltd._558.html", "defect": "Failed identity test on incoming primary raw material.", "claimed_cause": "Reliance on supplier COAs without adequate identity testing.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to conduct an identity test on each lot of raw material used in the manufacture of your API."}
{"filename": "Hikal Limited_322.html", "defect": "Metallic particles present in API exceeding detection limits", "claimed_cause": "No exact root cause identified; cleaning deficiency likely.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation failed to adequately determine the root cause of metal contamination in your APIs, particularly regarding the qualification of your metal detector and the applicability of industry standards."}
{"filename": "Gadal Laboratories Inc._1554.html", "defect": "Inadequate cleaning processes and verification, leading to contamination.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to adequately validate production and process controls, including a lack of assurance that products consistently meet quality attributes and a failure to consider critical factors like system maintenance and seasonal variations during validation efforts."}
{"filename": "Cdymax India Pharma Private Limited_120.html", "defect": "Sample solution contamination during preparation of stability samples.", "claimed_cause": "Sample solution contamination during preparation.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation lacked scientific and thorough root cause analysis, failing to identify the contaminant, its origin, or the cause of its presence within your samples."}
{"filename": "Magnolia Medical Technologies Inc._2759.html", "defect": "Premature retraction of butterfly needles, incorrect IFU designations.", "claimed_cause": "Premature retraction, sterilization application, shelf-life failure. \nIncorrect IFU designations, rework, and distribution.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your firm did not adequately investigate and correct all affected products identified in CAR C00050."}
{"filename": "Evi Labs LLC_495.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a comprehensive assessment of your overall system for investigating deviations, discrepancies, complaints, and failures."}
{"filename": "Centaur Pharmaceuticals Private Ltd._1658.html", "defect": "Unlabeled vials of solution processed in HPLC system.", "claimed_cause": "Operator error (labeling, verification) and inadequate SOP revisions.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation failed to determine the scope of the deficiency and provide a root cause analysis regarding the discarding and shredding of critical CGMP documents."}
{"filename": "Kabe Labortechnik GmbH_528.html", "defect": "Partially damaged capillary tubes due to machine failure.", "claimed_cause": "Equipment malfunction/failure of the \u201c (b)(4) \u201d machine.", "product_type": "Medical devices", "fda_critique": "The investigation lacked evidence of retroactive qualification and a systemic corrective action to ensure all equipment meets specified requirements and is appropriately qualified for its intended use."}
{"filename": "Integra LifeSciences Corporation_745.html", "defect": "Out-of-specification (OOS) endotoxin results on surgical patties and Duraform lots", "claimed_cause": "Re-testing failed CV% exceeded limit.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation lacked a thorough evaluation of the underlying causes for the repeated CV% exceedances and failures."}
{"filename": "Zermat International S.A. de C.V._1799.html", "defect": "Out-of-specification viscosity and specific gravity results.", "claimed_cause": "Inadequate OOS investigation; specification error and wrong criteria.", "product_type": "Oral solid dosage", "fda_critique": "Your firm failed to thoroughly investigate out-of-specification results and discrepancies, including the release and distribution of batches with OOS viscosity and specific gravity results without an investigation or supporting evidence."}
{"filename": "Sunstar Americas Inc._2603.html", "defect": "Burkholderia contaminans contamination in water system ports", "claimed_cause": "Operator error, deviations, and lack of investigation/CAPA.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to thoroughly investigate unexplained discrepancies, such as the identification of *Burkholderia contaminans* in multiple water system samples and staining within the water tank, resulting in a lack of documented corrective and preventative actions."}
{"filename": "Sanitor Corporation_2655.html", "defect": "Too Numerous to Count (TNTC) microbial counts in hand sanitizer.", "claimed_cause": "Inadequately robust procedures; lack thorough root cause investigation.", "product_type": "Oral solid dosage", "fda_critique": "Your firm did not provide a thorough investigation into the microbial failures and failed to identify the root cause and implement appropriate corrective action strategies."}
{"filename": "Apotex Inc._156.html", "defect": "Container-closure integrity issues and product leakage.", "claimed_cause": "Production personnel used the closure to fill products without addressing uncertainty.", "product_type": "Oral solid dosage", "fda_critique": "Your firm failed to thoroughly investigate unexplained failures and their impact on potentially affected batches, particularly regarding container-closure integrity issues and product leakage."}
{"filename": "Cetylite Industries Inc._2391.html", "defect": "Out-of-specification (OOS) test result for tetracaine HCl potency.", "claimed_cause": "\u201cYour firm attributed the failure to repeated testing achieving passing results.\u201d", "product_type": "Topical products", "fda_critique": "The firm failed to provide scientifically sound justification for repeatedly testing the sample until a passing result was achieved, despite an initial OOS test result using a compendial method."}
{"filename": "Shiva Analyticals Private Limited_390.html", "defect": "Out-of-specification (OOS) results for laboratory tests", "claimed_cause": "Inadequate investigation of OOS results and trends.", "product_type": "Oral solid dosage", "fda_critique": "Failed to thoroughly investigate unexplained discrepancies and OOS results lacking adequate scientific rationale and root cause analyses."}
{"filename": "Cipla Limited_1394.html", "defect": "Particles from MDI valves lodged in actuators, blocking drug delivery.", "claimed_cause": "Particles from MDI valves blocked actuators; no root cause identified.", "product_type": "Oral solid dosage", "fda_critique": "Your investigation lacked appropriate and timely corrective actions and preventive actions, and failed to extend investigations to other potentially affected batches."}
{"filename": "CTK OTC Laboratories LLC formerly FMK LABS Inc._504.html", "defect": "Subpotent API concentration in bulk base batch", "claimed_cause": "Root cause not determined; inadequate investigation process.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigations were inadequate because you failed to thoroughly investigate unexplained discrepancies and failures in drug products, including OOS results, without identifying root causes, implementing appropriate CAPA, or evaluating the impact on other batches."}
{"filename": "InfuTronix LLC_2194.html", "defect": "Crack in the filter of an administration set.", "claimed_cause": "No cause could be established; investigation not performed.", "product_type": "Medical devices", "fda_critique": "Your firm did not adequately review, evaluate, and investigate complaints involving device failures to meet specifications, often concluding investigations without returning the device or referencing prior investigations."}
{"filename": "Clinical Resolution Laboratory Inc._2392.html", "defect": "Drug products released prior to completion of quality control testing.", "claimed_cause": "\u201cDue to the belief that such could be proceeded to next step.\u201d", "product_type": "Topical products", "fda_critique": "Your investigation lacked a retrospective review to identify other instances of drug product release prior to completion of quality control testing."}
{"filename": "Liebel-Flarsheim Company LLC_153.html", "defect": "Bioburden excursions exceeding microbial action-level limits.", "claimed_cause": "Root cause was identified as \u201cpersonnel\u201d or \u201cenvironment\u201d without sufficient evidence.", "product_type": "Injectable drugs", "fda_critique": "Failed to adequately investigate microbial excursions and OOS endotoxin results, lacking scientifically justified root causes and a thorough risk assessment."}
{"filename": "Natco Pharma Limited_1173.html", "defect": "Missing batch record pages, changed sample weight, and printout discrepancies.", "claimed_cause": "Inattention of manufacturing operators, analyst error.", "product_type": "Oral solid dosage", "fda_critique": "Your investigations were inadequate due to failing to thoroughly investigate discrepancies and lack a root cause determination supported by evidence, leading to conclusions based on probable causes like operator inattention without sufficient evidence."}
{"filename": "Hong Qiangxing Shenzhen Electronics Limited_108.html", "defect": "Inadequate software validation for TENS/PMS Model SM9109A", "claimed_cause": "Lack of planning, inadequate evaluation, and insufficient documentation.", "product_type": "Medical devices", "fda_critique": "Your firm failed to adequately review previously manufactured devices for software validation and did not address the retrospective review needed to ensure compliance."}
{"filename": "Cangene BioPharma LLC dba Emergent BioSolutions_2180.html", "defect": "Particulate contamination of sterile drug products due to tray units.", "claimed_cause": "Manipulation of tray units led to metal particulates.", "product_type": "Medical devices", "fda_critique": "Your investigation lacked sufficient evaluation and documentation regarding the root cause of particulate contamination, particularly failing to adequately address the inadequate tray unit design and maintenance procedures."}
{"filename": "Abiomed Inc._1466.html", "defect": "Burr on Impeller CP below target tolerance", "claimed_cause": "NONE IDENTIFIED", "product_type": "Medical devices", "fda_critique": "Your firm failed to adequately validate corrective actions, specifically the software bug fix, to ensure it effectively addressed the issue and did not adversely affect the finished device."}
{"filename": "Medgel Private Limited_1627.html", "defect": "Out-of-specification assay results lacking adequate scientific justification.", "claimed_cause": "Sample preparation error without adequate scientific justification, defective dehumidifier.", "product_type": "Oral solid dosage", "fda_critique": "Your investigations into out-of-specification assay results lacked adequate hypothesis testing and scientific justification for determining the root cause."}
{"filename": "Allay Pharmaceuticals LLC_3230.html", "defect": "Exceeded assay specification for active ingredient in tablets.", "claimed_cause": "Lack of stability testing, inconsistent disintegration testing, delayed stability study.", "product_type": "Oral solid dosage", "fda_critique": "The company\u2019s investigation failed to identify and address the 13 lots within expiry that exceeded the revised assay specification, and lacked a thorough investigation into the stability characteristics of drug products."}
{"filename": "Indiana Chem-Port_2545.html", "defect": "Lack of proper drug listings with the FDA.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a complete assessment of the inaccuracies in data records and reporting, including a detailed description of the scope and root causes of the data integrity lapses."}
{"filename": "Amman Pharmaceutical Industries_1250.html", "defect": "Contaminated microbiological samples and inaccurate data recording.", "claimed_cause": "Operator error, data breaches, and inadequate procedures.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The firm failed to fully consider the gaps and uncertainties in a retrospective review when there has been a significant adverse pattern of data that was overwritten, discarded, and unrecorded."}
{"filename": "Chemical Services Group Inc.Royal Chemical Company_1801.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your firm\u2019s investigation system lacked a comprehensive assessment and remediation plan to ensure effective investigation competencies, scope determination, root cause evaluation, and CAPA effectiveness."}
{"filename": "CardioQuip LLC_2503.html", "defect": "Bacterial contamination on MCH devices", "claimed_cause": "Tolerance stacking with device specifications at edges.", "product_type": "Medical devices", "fda_critique": "The firm\u2019s investigation lacked adequate evaluation of contamination levels and causes, failing to investigate the bacterial contamination identified in complaints."}
{"filename": "Choice All Natural Inc. dba Om Botanical_851.html", "defect": "Candida parapsilosis contamination", "claimed_cause": "NONE IDENTIFIED", "product_type": "Topical products", "fda_critique": "Your firm failed to include results of an investigation into potentially contaminated drug product batches."}
{"filename": "Fresenius Kabi AG_1482.html", "defect": "TNTC bioburden results in bulk solutions/finished units", "claimed_cause": "Failure to evaluate root causes, batches released despite excursions.", "product_type": "Biologics", "fda_critique": "The company\u2019s investigation lacked a thorough evaluation to determine the root cause of excursions and failed to establish that its sterilization process could achieve its established minimum sterility assurance level when TNTC bioburden levels were present."}
{"filename": "Intas Pharmaceuticals Limited_1381.html", "defect": "White particles and glass particles exceeding action levels", "claimed_cause": "NONE IDENTIFIED", "product_type": "Injectable drugs", "fda_critique": "The firm failed to thoroughly investigate deviations and batch failures, particularly regarding the identification and source of particulates exceeding action levels."}
{"filename": "LiquidCapsule Manufacturing LLC_22.html", "defect": "Incomplete batch production and control records lacking full testing results.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Failed to expand their review to all drug products, in individual configurations, for lots previously distributed and within expiry, and did not investigate the root cause of incomplete documentation."}
{"filename": "Accu Bio-Chem Laboratories_2491.html", "defect": "Out-of-specification assay results for OTC drug products", "claimed_cause": "Your firm attributed the failure to inadequate OOS investigation procedures.", "product_type": "Oral solid dosage", "fda_critique": "Failed to thoroughly investigate out-of-specification results and provide a retrospective review of invalidated OOS results over the past three years."}
{"filename": "Beckman Coulter Inc._1190.html", "defect": "Shorting of PCBs within the DxI 600/800 Analyzer", "claimed_cause": "Design change to PCB caused shorting.", "product_type": "Medical devices", "fda_critique": "The investigation lacked adequate assessment of the design change\u2019s impact on other devices and failed to sufficiently identify the root cause related to design, verification, and validation processes."}
{"filename": "Glicerinas Industriales S.A. de C.V._1309.html", "defect": "Unidentified colored particulates in repackaged glycerin, propylene glycol, and other components.", "claimed_cause": "Operator error, investigation failure, root cause not identified.", "product_type": "Oral solid dosage", "fda_critique": "Your investigation failed to adequately investigate over 100 lots contaminated with particulates and assess the safety risk of contaminated drugs released to customers."}
{"filename": "Sircle Laboratories LLC_2762.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "The company\u2019s investigation lacked a retrospective review to ensure appropriate labeling was on all products currently in distribution."}
{"filename": "Premier Nutra Pharma Inc._1775.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Lacked a comprehensive investigation into the root causes of contamination, including inadequate procedures for reviewing batch records, CAPA, and deviations."}
{"filename": "Seatex LLC_1123.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked scientific justification for concluding operator error and failed to adequately address potential manufacturing root causes."}
{"filename": "ALI Pharmaceutical Manufacturing LLC_1439.html", "defect": "Bacillus cereus contamination in porcine thyroid API", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked sufficient detail regarding the root causes of contamination and failed to investigate all lots with potential objectionable microbial contamination or OOS results."}
{"filename": "Toyobo Co. Ltd._2866.html", "defect": "Significant particulate contamination in sterile injection solution.", "claimed_cause": "\u201cHighly possible\u201d washing/sterilization issues, formulation source, inadequate CAPA.", "product_type": "Sterile products", "fda_critique": "Failed to adequately investigate both extrinsic and intrinsic particulate contamination issues, including the root cause and implementing a timely and effective CAPA."}
{"filename": "Adamson Analytical Laboratories Inc._2725.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to provide copies of the updated change control form and Standard Operating Procedure for review, and did not commit to a systematic retrospective review of changes and their impact on drug analyses."}
{"filename": "Oasis Medical Inc._381.html", "defect": "Visible particulate contamination in sterile ophthalmic drug products", "claimed_cause": "Operator error and lack of process control identified.", "product_type": "Ophthalmic products", "fda_critique": "The company\u2019s investigation failed to thoroughly investigate the root causes of visible particulate contamination and excessive defects, lacking a commitment to remediate a low-capability process and prevent further contaminated batches from being produced."}
{"filename": "Global Calcium Pvt. Limited_726.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a comprehensive assessment of omissions, alterations, deletions, record destruction, and other deficiencies within the facility\u2019s operations regarding data integrity."}
{"filename": "LeMaitre Vascular Inc._341.html", "defect": "Failed sterility test results from testing (b)(4)", "claimed_cause": "\u201cInvestigation concluded \u2018causes unrelated to the product\u2019 were invalid.\u201d", "product_type": "Sterile products", "fda_critique": "Your investigation lacked sufficient justification for repeating the sterility test and failing to verify effectiveness for previously closed SCARs."}
{"filename": "Absara Cosmetics S.A.P.I DE C.V._3200.html", "defect": "Average 58% ethanol concentration in hand sanitizer product.", "claimed_cause": "The investigation concluded the subpotency was limited to one batch.", "product_type": "Other", "fda_critique": "The investigation lacked adequate scientific justification to support the conclusion that the subpotent issue was limited to only the FDA-tested batch and failed to expand the investigation to include all impacted products and batches."}
{"filename": "Novel Laboratories Inc. d.b.a LUPIN_2973.html", "defect": "Out-of-specification (OOS) results for content uniformity", "claimed_cause": "Suboptimal process performance was the root cause identified.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your firm did not provide assurance that batches released to the U.S. market, manufactured before validation, are of the appropriate strength and quality."}
{"filename": "Scientific Protein Laboratories LLC_158.html", "defect": "Foreign particles introduced as a result of the manufacturing process.", "claimed_cause": "Sampling procedure as the potential root cause.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigations lacked an adequate root cause analysis to assess all sources of variability in your manufacturing process that could be contributing to failures, particularly regarding cleaning procedures and the potential for masking failing testing results."}
{"filename": "Chromatography Institute of America dba Compounders International Analytical Laboratory_334.html", "defect": "Failed sterility test \u2013 microbial growth detected", "claimed_cause": "Technician error \u2013 environmental contamination", "product_type": "Sterile products", "fda_critique": "You did not adequately investigate the multiple failed sterility test results by failing to support the \u201ctechnician error \u2013 environmental contamination\u201d root cause with supporting environmental monitoring data."}
{"filename": "Rhyz Analytical Labs_94.html", "defect": "Microbial excursions in drug product lots failing specifications", "claimed_cause": "\u201cUnknown laboratory error\u201d and \u201ccontamination of an unknown source.\u201d", "product_type": "Oral solid dosage", "fda_critique": "Your investigation lacked sufficient scientific justification to conclude \u201cunknown laboratory error\u201d and failed to adequately investigate potential contamination sources."}
{"filename": "Seatex LLC_1104.html", "defect": "NOT SPECIFIED (The letter focuses on documentation and investigation practices, not a specific product defect.)", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Failed to conduct at least one test to verify the identity of each component of a drug product and failed to validate and establish the reliability of component supplier\u2019s test analyses."}
{"filename": "Kilitch Healthcare India Limited_1182.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Sterile products", "fda_critique": "Your investigation failed to ensure complete data derived from necessary tests and accurately collected environmental and personnel monitoring samples, leading to fabricated or altered results."}
{"filename": "Colgate-PalmoliveToms of Maine Inc._820.html", "defect": "Multiple objectionable microorganisms (Pseudomonas, Ralstonia, Paracoccus) in water.", "claimed_cause": "Laboratory error related to sample contamination was the root cause.", "product_type": "Oral solid dosage", "fda_critique": "Failed to adequately investigate and assess the impact of microbial contamination, particularly regarding water system performance and finished product quality."}
{"filename": "Hubei Kangzheng Pharmaceutical Co. Ltd._2613.html", "defect": "Different infrared (IR) spectrum of naphazoline HCl API.", "claimed_cause": "You stated that a new lab IR test conformed to the standard.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your firm failed to initiate an investigation to determine a root cause for the unknown peaks that were detected in your finished drug product batches and implement a CAPA to prevent reoccurrence."}
{"filename": "Fulijaya Manufacturing SDN. BHD._1.html", "defect": "Lack of growth promotion testing of microbiological media.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Failed to conduct growth promotion testing of microbiological media and independently verify supplier certificates of analysis, leading to inadequate assurance of component suitability."}
{"filename": "Wittman Pharma Inc._894.html", "defect": "Objectionable microorganisms detected in the water system.", "claimed_cause": "Lack of investigation, inadequate procedures, and unqualified water system.", "product_type": "Oral solid dosage", "fda_critique": "Failed to conduct adequate investigations into the presence of objectionable microorganisms and other excursions in their water system."}
{"filename": "EyePoint Pharmaceuticals Inc._953.html", "defect": "Atypical drug core release rate exceeding specification.", "claimed_cause": "Failure to investigate discrepancies, lacking root cause analysis.", "product_type": "Combination products", "fda_critique": "Failed to consistently conduct investigations in a timely manner to ensure other batches were not similarly affected."}
{"filename": "Absolutely Natural_21.html", "defect": "Out-of-specification microbiological testing results for Pseudomonas aeruginosa", "claimed_cause": "Operator error during batch preparation, inadequate investigation.", "product_type": "Oral solid dosage", "fda_critique": "Your investigation did not adequately assess additional drug products that may have been affected by the microbiological contamination."}
{"filename": "RemedyRepack Inc._1727.html", "defect": "Broken tablets caused by packaging equipment malfunction.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Your investigation failed to extend to other potentially affected batches and implement CAPA plans to prevent recurring issues."}
{"filename": "DFI Co. Ltd._513.html", "defect": "False negative/positive readings from device analysis strips", "claimed_cause": "Complaint handling was informally managed by the sales department.", "product_type": "Medical devices", "fda_critique": "Your firm did not include a description or evidence that the specific complaints identified in the FDA 483 have been investigated."}
{"filename": "Sun Pharmaceutical Industries Ltd._1457.html", "defect": "Inappropriately designed vial filling equipment introduced metallic particles.", "claimed_cause": "Friction from damaged equipment introduced metallic particles during filling.", "product_type": "Injectable drugs", "fda_critique": "Your investigation failed to adequately address the continued use of damaged and inappropriately designed equipment, including a lack of risk assessment for the lifecycle control of manufacturing equipment."}
{"filename": "Siddha Flower Essences LLC. dba Siddha Remedies_118.html", "defect": "Microbiological contamination of aqueous drug products", "claimed_cause": "Lack qualified personnel, insufficient oversight, and unclear root cause.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation failed to thoroughly investigate out-of-limit microbiological results and identify root causes, lacking a clear timeline and interim plans for drug production until the full scope of impact was determined."}
{"filename": "Cosmetic Specialty Labs Inc._1233.html", "defect": "Lack of process validation, including inadequate microbiological testing.", "claimed_cause": "Inadequate written procedures, process validation, and lack of specifications.", "product_type": "Oral solid dosage", "fda_critique": "The firm failed to adequately review all batches distributed prior to testing, ensuring they met appropriate specifications for identity, strength, quality, and purity."}
{"filename": "Generitech Corporation_2434.html", "defect": "Out-of-specification assay results for salicylic acid.", "claimed_cause": "Lack of resources/personnel to investigate; no root cause.", "product_type": "Topical products", "fda_critique": "Failed to thoroughly investigate unexplained OOS assay results and determine a root cause or assess the impact of the results."}
{"filename": "Randox Laboratories Limited_743.html", "defect": "Carryover of precedent assay reagents causing erroneous analyzer results", "claimed_cause": "Ambiguity in risk analysis, lack of responsibility, file maintenance issues.", "product_type": "Medical devices", "fda_critique": "Your firm did not adequately address the root cause of carryover issues by failing to provide copies of the risk management files for review and lacking a clear explanation of how the revised job description will prevent similar failures."}
{"filename": "Sun Pharmaceutical Industries Limited_1050.html", "defect": "Stagnant liquid with microbial contamination in equipment.", "claimed_cause": "Faulty valve failure was the root cause identified.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation failed to provide a comprehensive, independent retrospective assessment of cleaning effectiveness to evaluate the scope of cross-contamination hazards."}
{"filename": "Uscom Kft_349.html", "defect": "Not specified", "claimed_cause": "NONE IDENTIFIED", "product_type": "Medical devices", "fda_critique": "Your investigation lacked adequate validation of the SpiroSonic Mobile Software V1.16 and the cleaning and disinfection process for SpiroThor, with no documented rationale or new procedure provided."}
{"filename": "Outin Futures Corp._868.html", "defect": "Out-of-specification assay test failing to meet release specification.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "Your firm failed to establish a quality control unit with the authority and procedures necessary to effectively oversee all aspects of drug product quality and investigate OOS results."}
{"filename": "Amneal Pharmaceuticals LLC_336.html", "defect": "Visible particulate contamination in injectable products", "claimed_cause": "NONE IDENTIFIED", "product_type": "Injectable drugs", "fda_critique": "The company\u2019s investigation lacked a comprehensive assessment of its overall system for investigating deviations and failures, including significant improvements in scope determination, root cause evaluation, and CAPA effectiveness."}
{"filename": "Sichuan Deebio Pharmaceutical Co. Ltd._1256.html", "defect": "Not having written down test results/data records.", "claimed_cause": "NOT STATED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The company\u2019s investigation was inadequate because it failed to perform a sufficient retrospective review of investigations and data retention deficiencies."}
{"filename": "Rechon Life Science AB_511.html", "defect": "Persistent contamination of objectionable microorganisms (gram-negative, spore formers)", "claimed_cause": "Operators talking and staff illness; non-functional injector syringe.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation into the trend of gram-negative organisms was inadequate because it did not provide a holistic evaluation of all potential contamination sources and personnel practices contributing to the adverse trend."}
{"filename": "MMC Healthcare Ltd._872.html", "defect": "Lack of appropriate controls in UV-Vis spectrophotometer computer system.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Other", "fda_critique": "The investigation lacked sufficient details regarding security features, user access levels, and data integrity measures for computerized analytical instrumentation systems."}
{"filename": "Medtronic Inc._2623.html", "defect": "Damaged retainer rings in insulin infusion pumps", "claimed_cause": "Risk calculation formula underestimated probability of harm.", "product_type": "Combination products", "fda_critique": "Your investigation failed to accurately calculate the risk associated with the failed retainer rings, resulting in an inappropriate risk classification."}
{"filename": "Tyche Industries Ltd_705.html", "defect": "Inaccurate and incomplete data records related to manufacturing.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation lacked a comprehensive assessment of the extent of inaccuracies in data records and reporting, including root causes and potential risks to drug quality and patient safety."}
{"filename": "System Kosmetik Produktionsgesellschaft fur kosmetische Gmbh_2087.html", "defect": "NOT SPECIFIED", "claimed_cause": "NONE IDENTIFIED", "product_type": "Oral solid dosage", "fda_critique": "The firm failed to exercise appropriate controls over computer or related systems to assure data integrity, specifically lacking unique usernames and passwords and disabling the audit trail function on a routinely used FTIR system."}
{"filename": "Olympus Medical Systems Corp._1827.html", "defect": "Cracked caps with tissue caught in the device tip.", "claimed_cause": "Lack of linkage between scopes and caps.", "product_type": "Medical devices", "fda_critique": "Your firm did not adequately investigate why the complaint regarding esophageal trauma and cracked caps was not initiated within the required 30-day timeframe."}
{"filename": "Unexo Lifesciences Private Limited_818.html", "defect": "Inaccuracies in data records and reporting.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a comprehensive assessment of the extent of data integrity deficiencies, including omissions, alterations, and deletions from raw data and results."}
{"filename": "Midlab Incorporated_1835.html", "defect": "Out-of-specification assay results for chloroxylenol concentration.", "claimed_cause": "Failure to investigate OOS results, lack of testing strategy.", "product_type": "Oral solid dosage", "fda_critique": "The investigation lacked a thorough investigation into unexplained OOS assay results and failed to ensure consistent production of safe and effective products."}
{"filename": "Creative Essences Inc._193.html", "defect": "Out-of-specification dissolution results for tablets", "claimed_cause": "Inadequate investigations; failure to identify root causes.", "product_type": "Oral solid dosage", "fda_critique": "Failed to thoroughly investigate unexplained discrepancies, OOS results, and failures, lacking sufficient scientific justification and detailed corrective action plans."}
{"filename": "Glenmark Pharmaceuticals Limited_1972.html", "defect": "Out-of-specification assay results for desmopressin acetate tablets", "claimed_cause": "Lack of defined compression parameters attributed to the content uniformity failure.", "product_type": "Oral solid dosage", "fda_critique": "Your investigations into rejected batches failed to extend to other batches, dosage strengths, and drug products for tablet compression machine settings."}
{"filename": "FirstCham Co. Ltd._1185.html", "defect": "Inadequate oversight of drug product quality and specifications.", "claimed_cause": "Operator error, inadequate oversight, and insufficient procedures.", "product_type": "Oral solid dosage", "fda_critique": "The investigation lacked a comprehensive assessment and remediation plan to ensure adequate quality oversight and a robust system for investigating deviations and failures."}
{"filename": "Intercos Europe S.p.A_965.html", "defect": "Microbial excursions exceeding limits in the manufacturing system.", "claimed_cause": "Sampling error, supervisor change, no product impact stated.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "You failed to provide a retrospective review of your microbial results and lack a risk assessment of all products that may have been affected by OOS results."}
{"filename": "Hologic Inc._744.html", "defect": "Breast discomfort/pain, erythema, itching sensation, burning sensation, infection, scar tissue", "claimed_cause": "No justification for severity level 4/5 CAPA delay.", "product_type": "Medical devices", "fda_critique": "Your firm did not calculate the occurrence rate accurately when evaluating a spike of BioZorb medical device complaints and Medical Device Reports, nor did it provide sufficient instructions for calculating an accurate occurrence rate when complaint spikes and adverse trends are identified."}
{"filename": "Centrient Pharmaceuticals India Private Limited_1966.html", "defect": "Black particles in API batches", "claimed_cause": "Non-metallic charred product residue.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "Your investigation failed to provide documented data to support your conclusions regarding the root cause of black particles in the API batches."}
{"filename": "Owens  Minor Inc. dba American Contract Systems Inc._825.html", "defect": "Sterilization bag lots failed thickness requirements.", "claimed_cause": "Operator error during bag acceptance and design verification activities.", "product_type": "Medical devices", "fda_critique": "Your response did not provide a systemic description of how your firm will prevent this significant failure from recurring."}
{"filename": "Aire-Master of America Inc._2308.html", "defect": "Foul odor in foaming hand sanitizer formulation water.", "claimed_cause": "\u201cChecked inventory and reworked product to lessen the smell.\u201d", "product_type": "Oral solid dosage", "fda_critique": "Your investigation lacked meaningful corrective action and preventive action to prevent recurrence, failing to address why the formulation water had a foul odor."}
{"filename": "CellEra LLC_2731.html", "defect": "Claims in Instructions for Use (IFUs) deviate from Agency clearance.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Medical devices", "fda_critique": "Your response did not adequately address the creation of a procedure for CAPA activities or your plan to document corrective and preventive actions."}
{"filename": "Acme United Corporation_174.html", "defect": "Recalcitrant biofilm development in a non-recirculating water system.", "claimed_cause": "Recalcitrant biofilm development due to stagnant, non-recirculating water.", "product_type": "Topical products", "fda_critique": "Your firm failed to conduct timely and comprehensive investigations into out-of-limit microbiological results, including documenting root cause determinations and product impact assessments."}
{"filename": "JAS DiagnosticsDrew Scientific Inc._2171.html", "defect": "Broken/damaged/wet products, leaking bottles, and particle contamination in diluent.", "claimed_cause": "\u201cExcessive heat\u201d from induction sealer settings caused polymer melting.", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked extending its evaluation to determine root causes, identifying other potentially affected products, and implementing corrective actions, particularly regarding open CAPAs like 21-002 and 21-001."}
{"filename": "Global Pharma Healthcare Private Limited_1408.html", "defect": "Leaking container-closure systems allowing microbiological ingress.", "claimed_cause": "Lack of comprehensive investigation; root cause not stated.", "product_type": "Topical products", "fda_critique": "The company\u2019s investigation lacked comprehensive details, root cause analysis, and sufficient testing, including sterility testing, regarding the contamination of its Artificial Tears and Artificial Eye Ointment products."}
{"filename": "S  J International Enterprises Public Company Limited_1304.html", "defect": "Lack of legible labeling and a raw material OOS entry.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Other", "fda_critique": "The investigation lacked complete and attributable batch records, and failed to provide legible documentation, including photographic evidence, upon request."}
{"filename": "Bi-Coastal Pharma International_2221.html", "defect": "Failed investigation of adverse reaction complaint regarding Chlordiazepoxide HCl/Clidinium Br.", "claimed_cause": "CMO was no longer in business, no cause identified.", "product_type": "Drugs", "fda_critique": "Failed to provide evidence of their investigation into the product quality impact of the complaint, including the two batches of Chlordiazepoxide HCl and Clidinium Br, 5 mg/2.5 mg manufactured since 2018."}
{"filename": "Viatris Inc._764.html", "defect": "Out-of-trend and out-of-specification dissolution results for tablets", "claimed_cause": "HPLC column leakage, improper sample set sequence, and OOS results.", "product_type": "Oral solid dosage", "fda_critique": "Your investigations lacked adequate scientific rationale and failed to thoroughly investigate unexplained discrepancies or out-of-specification results."}
{"filename": "Honest Globe Inc._3128.html", "defect": "Out-of-specification (OOS) camphor assay release testing results", "claimed_cause": "Operator error, inadequate procedures, and insufficient quality oversight.", "product_type": "Topical products", "fda_critique": "Your investigation failed to adequately investigate potential manufacturing deficiencies that led to out-of-specification test results and subsequent batch releases."}
{"filename": "Optikem International Inc._1041.html", "defect": "Inaccuracies in data records and reporting.", "claimed_cause": "NONE IDENTIFIED", "product_type": "Active pharmaceutical ingredients (API)", "fda_critique": "The investigation lacked a comprehensive assessment of the extent of data integrity deficiencies, including omissions, alterations, and deletions from data records."}
